These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7655432)

  • 1. Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.
    Matsuo H; Yamashita C; Akiyama K; Kiwada H
    Biol Pharm Bull; 1995 Apr; 18(4):581-5. PubMed ID: 7655432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma factor triggering alternative complement pathway activation by liposomes.
    Funato K; Yamashita C; Kamada J; Tominaga S; Kiwada H
    Pharm Res; 1994 Mar; 11(3):372-6. PubMed ID: 8008701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ.
    Matsuo H; Funato K; Harashima H; Kiwada H
    J Drug Target; 1994; 2(2):141-6. PubMed ID: 8069591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes.
    Yamashita C; Sone S; Ogura T; Kiwada H
    Jpn J Cancer Res; 1991 May; 82(5):569-76. PubMed ID: 1905703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.
    Ferdous AJ; Ishida T; Shinohara M; Harashima H; Kiwada H
    Biopharm Drug Dispos; 1996 Mar; 17(2):145-54. PubMed ID: 8907721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.
    Funato K; Yoda R; Kiwada H
    Biochim Biophys Acta; 1992 Jan; 1103(2):198-204. PubMed ID: 1543704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.
    Huong TM; Ishida T; Harashima H; Kiwada H
    Int J Pharm; 2001 Mar; 215(1-2):197-205. PubMed ID: 11250105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome clearance from blood: different animal species have different mechanisms.
    Liu D; Hu Q; Song YK
    Biochim Biophys Acta; 1995 Dec; 1240(2):277-84. PubMed ID: 8541299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody dependent, complement mediated liver uptake of liposomes containing GM1.
    Liu D; Song YK; Liu F
    Pharm Res; 1995 Nov; 12(11):1775-80. PubMed ID: 8592685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes.
    Ishida T; Yasukawa K; Kojima H; Harashima H; Kiwada H
    Int J Pharm; 2001 Aug; 224(1-2):69-79. PubMed ID: 11472816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
    Chonn A; Cullis PR; Devine DV
    J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes.
    Harashima H; Sakata K; Funato K; Kiwada H
    Pharm Res; 1994 Mar; 11(3):402-6. PubMed ID: 8008707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-complement interactions in rat serum: implications for liposome survival studies.
    Devine DV; Wong K; Serrano K; Chonn A; Cullis PR
    Biochim Biophys Acta; 1994 Apr; 1191(1):43-51. PubMed ID: 8155683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
    Szebeni J; Wassef NM; Spielberg H; Rudolph AS; Alving CR
    Biochem Biophys Res Commun; 1994 Nov; 205(1):255-63. PubMed ID: 7999033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement dependent and independent liposome uptake by peritoneal macrophages: cholesterol content dependency.
    Huong TM; Harashima H; Kiwada H
    Biol Pharm Bull; 1998 Sep; 21(9):969-73. PubMed ID: 9781849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation.
    Lee CM; Choi Y; Huh EJ; Lee KY; Song HC; Sun MJ; Jeong HJ; Cho CS; Bom HS
    Cancer Biother Radiopharm; 2005 Dec; 20(6):620-8. PubMed ID: 16398614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats.
    Moghimi SM; Patel HM
    Biochim Biophys Acta; 1996 Nov; 1285(1):56-64. PubMed ID: 8948475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of liposome-induced complement activation by surface-bound albumin.
    Savay S; Szebeni J; Baranyi L; Alving CR
    Biochim Biophys Acta; 2002 Feb; 1559(1):79-86. PubMed ID: 11825590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.